Sutro Biopharma, Inc.

STRONASDAQ • USD
8.76 USD
↘ 0.57 (6.06%)🟢LIVE (AS OF 01:55 PM EST)
🟢Market: OPEN

Sutro Biopharma, Inc. (STRO) trades at $8.76 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (117.2%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, STRO appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$9.36
High?$9.62
Low?$8.71
Prev. Close?$9.32
Volume?103.0K
Avg. Volume?335.3K
VWAP?$8.90
Rel. Volume?0.31x
Bid / Ask
Bid?$7.66 × 100
Ask?$8.83 × 100
Spread?$1.17
Midpoint?$8.25
Valuation & Ratios
Market Cap?154.7M
Shares Out?16.6M
Float?15.0M
Float %?90.5%
P/E Ratio?N/A
P/B Ratio?-1.17
EPS?-$9.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Employees
128
Market Cap
154.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2018-09-27
Address
111 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-392-8412
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
86
Short Sent.?
35
Piotroski F-Score?2/9Weak
Altman Z-Score?-9.57Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?15.04%High
Short Interest?2.3M
Days to Cover?6.3
Free Float15.0M
Avg Daily Volume360.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?2.94Strong
Quick Ratio?2.94Strong
Cash Ratio?0.86Adequate
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
S&P
97
-1.17CHEAP▾
P/S?
Peers
100
S&P
45
3.43FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.0CHEAP▾
EV/Sales?
Peers
100
S&P
69
2.39CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
117.2%STRONG▾
ROA?
S&P
3
-87.9%WEAK▾
Cash Flow & Enterprise
FCF?$-129762000
Enterprise Value?$107.9M
Fundamentals ratios updated end of day